000 01387 a2200349 4500
005 20250518051737.0
264 0 _c20200608
008 202006s 0 0 eng d
022 _a1090-2104
024 7 _a10.1016/j.bbrc.2019.07.044
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCoughlin, Brandon A
245 0 0 _aInterleukin-6 (IL-6) mediates protection against glucose toxicity in human Müller cells via activation of VEGF-A signaling.
_h[electronic resource]
260 _bBiochemical and biophysical research communications
_c09 2019
300 _a227-232 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCells, Cultured
650 0 4 _aCytokine Receptor gp130
_ximmunology
650 0 4 _aDiabetic Retinopathy
_ximmunology
650 0 4 _aGlucose
_ximmunology
650 0 4 _aHumans
650 0 4 _aInflammation
_ximmunology
650 0 4 _aInterleukin-6
_ximmunology
650 0 4 _aReceptors, Interleukin-6
_ximmunology
650 0 4 _aRetina
_xcytology
650 0 4 _aSignal Transduction
650 0 4 _aVascular Endothelial Growth Factor A
_ximmunology
700 1 _aTrombley, Brett T
700 1 _aMohr, Susanne
773 0 _tBiochemical and biophysical research communications
_gvol. 517
_gno. 2
_gp. 227-232
856 4 0 _uhttps://doi.org/10.1016/j.bbrc.2019.07.044
_zAvailable from publisher's website
999 _c29926606
_d29926606